Design, synthesis and anticancer studies of novel aminobenzazolyl pyrimidines as tyrosine kinase inhibitors
R Chikhale, S Thorat, RK Choudhary, N Gadewal… - Bioorganic …, 2018 - Elsevier
Abnormal signalling from the Protein tyrosine kinases (PTKs) like receptor tyrosine kinases
and intracellular tyrosine kinases can lead to diseases such as cancer especially non-small …
and intracellular tyrosine kinases can lead to diseases such as cancer especially non-small …
Benzothiazoles: Search for anticancer agents
Novel derivatives of 2-amino benzothiazoles 4 (a–j) have been synthesized and tested for
their antitumor activity using National Cancer Institute (NCI) disease oriented antitumor …
their antitumor activity using National Cancer Institute (NCI) disease oriented antitumor …
Preparation of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides and Their Experimental and Computational Biological Studies
Pyrazolo [4, 3-e] tetrazolo [1, 5-b][1, 2, 4] triazine sulfonamides constitute a novel class of
heterocyclic compounds with broad biological activity, including anticancer properties …
heterocyclic compounds with broad biological activity, including anticancer properties …
Structural-based design, synthesis, and antitumor activity of novel alloxazine analogues with potential selective kinase inhibition
Protein kinases are promising therapeutic targets for cancer therapy. Here, we applied
multiple approaches to optimize the potency and selectivity of our reported alloxazine …
multiple approaches to optimize the potency and selectivity of our reported alloxazine …
Quinazolin-4(3H)-one based potential multiple tyrosine kinase inhibitors with excellent cytotoxicity
Abstract A series of quinazolin-4 (3 H)-one derivatives were synthesised and evaluated for
their cytotoxicity against human Caucasian breast adenocarcinoma (MCF-7) and human …
their cytotoxicity against human Caucasian breast adenocarcinoma (MCF-7) and human …
One Pot Single Step Synthesis and Biological Evaluation of Some Novel Bis(1,3,4-thiadiazole) Derivatives as Potential Cytotoxic Agents
A novel series of bis (1, 3, 4-thiadiazole) derivatives were synthesized in one step
methodology with good yields by condensation reaction between bis-hydrazonoyl chloride 1 …
methodology with good yields by condensation reaction between bis-hydrazonoyl chloride 1 …
Design, synthesis and evaluation of new bioactive oxadiazole derivatives as anticancer agents targeting bcl-2
A series of 2-(1 H-indol-3-yl)-5-substituted-1, 3, 4-oxadiazoles, 4a–m, were designed,
synthesized and tested in vitro as potential pro-apoptotic Bcl-2 inhibitory anticancer agents …
synthesized and tested in vitro as potential pro-apoptotic Bcl-2 inhibitory anticancer agents …
Synthesis, antiproliferative, antioxidant activities, in silico studies, DFT analysis and molecular dynamics simulation of novel 1-(4-chlorobenzhydryl) piperazine …
NA Al-Masoudi, RS Jihad, NA Abdul-Rida… - Journal of Molecular …, 2024 - Elsevier
Abstract A series of 1-(4-chlorobenzhydryl) piperazine derivatives 3–10 were synthesized
and characterized both spectroscopically and structurally to investigate their antiproliferative …
and characterized both spectroscopically and structurally to investigate their antiproliferative …
Assessment of elementary derivatives of 1, 5-benzodiazepine as anticancer agents with synergy potential
SJ Gawandi, VG Desai, S Joshi, S Shingade… - Bioorganic …, 2021 - Elsevier
Herein, we designed and synthesized 1, 5-benzodiazepines as a lead molecule for
anticancer activity and as potent synergistic activity with drug Methotrexate. Working under …
anticancer activity and as potent synergistic activity with drug Methotrexate. Working under …
Synthesis, in silico studies and in vitro cytotoxicity evaluation of novel posaconazole derivative as a ALK TK inhibitor
Oncology research progresses, yet cancer remains the largest medical need. The use of a
medication with an accessible lead molecule shows great potential for long-term cancer …
medication with an accessible lead molecule shows great potential for long-term cancer …